<DOC>
	<DOCNO>NCT01633723</DOCNO>
	<brief_summary>DA-6886_IBS_I phase I , dose block-randomized , double-blind , placebo-controlled , single/multiple dosing , dose escalation clinical trial open-labelled food effect study single dose investigate safety , tolerability pharmacokinetics DA-6886 oral administration healthy male subject .</brief_summary>
	<brief_title>Phase I Clinical Trial DA-6886 Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>20 ~ 45 year old 27kg/m2 ≥ BMI ≥ 20kg/m2 Healthy Male Informed consent Clinically significant medical history smoker Clinically significant hypersensitivity Drugs Clinically significant cutaneous disorder QTcB &gt; 450msec history drug abuse show positive drug abuse cotinine urine screening</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>